Osteopontin Depletion in Macrophages Perturbs Proteostasis and Leads to UCHL1 Deficiency and Mitochondria-Mediated Apoptosis
暂无分享,去创建一个
K. Black | K. Raedschelders | J. Dagvadorj | Y. Koronyo | M. Koronyo-Hamaoui | B. Gaire | A. Rentsendorj | M. Arditi | Haoshen Shi | D. Fuchs | J. Sheyn | J. V. Van Eyk | V. Vaibhav | Rebecca A. Porrit | Juliana De Freitas Germano
[1] M. Rossol,et al. Danger signal extracellular calcium initiates differentiation of monocytes into SPP1/osteopontin-producing macrophages , 2022, Cell death & disease.
[2] Kai-Yao Huang,et al. Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors , 2021, Cell reports.
[3] Yongliang Zhang,et al. Macrophage-Derived Osteopontin Influences the Amplification of Cryptococcus neoformans–Promoting Type 2 Immune Response , 2021, The Journal of Immunology.
[4] Daidi Fan,et al. Comparative Proteomic Analysis of Polarized Human THP-1 and Mouse RAW264.7 Macrophages , 2021, Frontiers in Immunology.
[5] E. Eleutherio,et al. SOD1, more than just an antioxidant. , 2020, Archives of biochemistry and biophysics.
[6] Jinning Song,et al. Recombinant osteopontin provides protection for cerebral infarction by inhibiting the NLRP3 inflammasome in microglia , 2020, Brain Research.
[7] Xuejun Wang,et al. UCHL1 regulates oxidative activity in skeletal muscle , 2020, PloS one.
[8] E. Klann,et al. Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer’s disease , 2020, Science Signaling.
[9] P. Shah,et al. Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models , 2020, Aging cell.
[10] O. Shirihai,et al. A new target for an old DUB: UCH-L1 regulates mitofusin-2 levels, altering mitochondrial morphology, function and calcium uptake , 2020, Redox biology.
[11] D. Teplow,et al. Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ42 Oligomers and Protect Synapses , 2020, Frontiers in Immunology.
[12] T. Isa,et al. Neuronal and microglial localization of secreted phosphoprotein 1 (osteopontin) in intact and damaged motor cortex of macaques , 2019, Brain Research.
[13] D. Bernardo,et al. Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis , 2019, Scientific Reports.
[14] G. Patti,et al. Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation , 2019, eLife.
[15] H. Herwald,et al. Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation , 2018, Allergy.
[16] D. Gozuacik,et al. Crosstalk Between Mammalian Autophagy and the Ubiquitin-Proteasome System , 2018, Front. Cell Dev. Biol..
[17] V. Vijayan,et al. The macrophage heme-heme oxygenase-1 system and its role in inflammation. , 2018, Biochemical pharmacology.
[18] Karla D. Passalacqua,et al. Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses , 2018, Scientific Reports.
[19] M. Fessler,et al. Comparative and network-based proteomic analysis of low dose ethanol- and lipopolysaccharide-induced macrophages , 2018, PloS one.
[20] M. Tabaton,et al. The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer’s and Vascular Disease , 2017, Front. Aging Neurosci..
[21] P. Bickford,et al. Proteomic anaysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response , 2017, Journal of Neuroinflammation.
[22] A. Chacińska,et al. Control of mitochondrial biogenesis and function by the ubiquitin–proteasome system , 2017, Open Biology.
[23] J. Henley,et al. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction , 2016, The Biochemical journal.
[24] M. Hayden,et al. Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition , 2016, Journal of Neuroimmunology.
[25] D. Butterfield,et al. It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease , 2016, Oxidative medicine and cellular longevity.
[26] J. Simpkins,et al. Sequential Upregulation of Superoxide Dismutase 2 and Heme Oxygenase 1 by tert-Butylhydroquinone Protects Mitochondria during Oxidative Stress , 2015, Molecular Pharmacology.
[27] L. Olson,et al. Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin? , 2015, International journal of molecular sciences.
[28] Keith L Black,et al. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease. , 2015, Brain : a journal of neurology.
[29] Lars Malmström,et al. Identification of a Set of Conserved Eukaryotic Internal Retention Time Standards for Data-independent Acquisition Mass Spectrometry* , 2015, Molecular & Cellular Proteomics.
[30] Ole N Jensen,et al. Two distinct modes for propagation of histone PTMs across the cell cycle , 2015, Genes & development.
[31] H. Cantor,et al. Intracellular osteopontin regulates homeostasis and function of natural killer cells , 2014, Proceedings of the National Academy of Sciences.
[32] Y. Naito,et al. Heme oxygenase-1 and anti-inflammatory M2 macrophages. , 2014, Archives of biochemistry and biophysics.
[33] T. M. Reeves,et al. Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury , 2014, Experimental Neurology.
[34] Yong-ming Yao,et al. Macrophage Polarization in Inflammatory Diseases , 2014, International journal of biological sciences.
[35] K. Black,et al. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline. , 2014, The Journal of clinical investigation.
[36] Alberto Mantovani,et al. Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.
[37] J. Heeren,et al. Low Density Lipoprotein Receptor-Related Protein 1 Dependent Endosomal Trapping and Recycling of Apolipoprotein E , 2012, PloS one.
[38] K. Black,et al. Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease. , 2011, Investigative ophthalmology & visual science.
[39] S. Rittling. Osteopontin in macrophage function , 2011, Expert Reviews in Molecular Medicine.
[40] G. Kovtunovych,et al. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. , 2010, Blood.
[41] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[42] M. Linton,et al. Macrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[43] P. K. Sobhan,et al. Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin‐induced apoptosis , 2010, Molecular carcinogenesis.
[44] I. Day,et al. UCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein , 2010, Progress in Neurobiology.
[45] R. Jackson,et al. The mechanism of eukaryotic translation initiation and principles of its regulation , 2010, Nature Reviews Molecular Cell Biology.
[46] M. Schwartz,et al. Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9 , 2009, Journal of neurochemistry.
[47] C. Giachelli,et al. The role of osteopontin in inflammatory processes , 2009, Journal of Cell Communication and Signaling.
[48] B. Brüne,et al. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. , 2009, Molecular biology of the cell.
[49] P. Syapin. Regulation of haeme oxygenase‐1 for treatment of neuroinflammation and brain disorders , 2008, British journal of pharmacology.
[50] Hao Wang,et al. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. , 2008, Arthritis and rheumatism.
[51] G. Diette,et al. Analysis of CD4+ T-cell gene expression in allergic subjects using two different microarray platforms. , 2008, Allergy. European Journal of Allergy and Clinical Immunology.
[52] L. Liaw,et al. Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[53] S. Youssef,et al. Type II monocytes modulate T cell–mediated central nervous system autoimmune disease , 2007, Nature Medicine.
[54] Michal Schwartz,et al. Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model , 2007, The European journal of neuroscience.
[55] B. E. Black,et al. Propagation of centromeric chromatin requires exit from mitosis , 2007, The Journal of cell biology.
[56] Michal Schwartz,et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[57] P. Walker,et al. Oxidative stress regulated expression of Ubiquitin Carboxyl-terminal Hydrolase-L1: Role in cell survival , 2006, Apoptosis.
[58] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[59] L. Glimcher,et al. T-bet-dependent expression of osteopontin contributes to T cell polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] M. Minami,et al. Neuroprotection by Osteopontin in Stroke , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[61] A E Willis,et al. Translation inhibition during the induction of apoptosis: RNA or protein degradation? , 2004, Biochemical Society transactions.
[62] M. Glimcher,et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.
[63] D. Laskin,et al. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages , 1996, Journal of leukocyte biology.
[64] K D Wilkinson,et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. , 1989, Science.
[65] F. Blattner,et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection , 1989, The Journal of experimental medicine.
[66] D. Heinegård,et al. Isolation and characterization of two sialoproteins present only in bone calcified matrix. , 1985, The Biochemical journal.
[67] R. Thompson,et al. Isolation of PGP 9.5, a New Human Neurone‐Specific Protein Detected by High‐Resolution Two‐Dimensional Electrophoresis , 1983, Journal of neurochemistry.
[68] K. Black,et al. Title A novel role for osteopontin in macrophage-mediated amyloid-beta clearance in Alzheimer ' s models , 2017 .
[69] Sarah J. Parker,et al. Methods for SWATH™: Data Independent Acquisition on TripleTOF Mass Spectrometers. , 2016, Methods in molecular biology.